High density lipoprotein measurement
|
phenotype |
|
Laboratory Procedure
|
545
|
1440
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
Ovarian Hyperstimulation Syndrome
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Disease or Syndrome
|
64
|
24
|
0.010 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Tension Headache
|
disease |
Nervous System Diseases
|
Disease or Syndrome
|
12
|
6
|
0.010 |
None |
1.000 |
1 |
1
|
2010 |
2010 |
Gallbladder Carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
498
|
75
|
0.010 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
Triglycerides measurement
|
phenotype |
|
Laboratory Procedure
|
563
|
1418
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
Pelvic Organ Prolapse
|
disease |
Pathological Conditions, Signs and Symptoms
|
Disease or Syndrome
|
119
|
49
|
0.010 |
None |
1.000 |
1 |
1
|
2009 |
2009 |
Serum HDL cholesterol measurement
|
phenotype |
|
Laboratory Procedure
|
283
|
679
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
Triple Negative Breast Neoplasms
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
1674
|
99
|
0.100 |
None |
0.781 |
151 |
|
2009 |
2020 |
Triple-Negative Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
1598
|
96
|
0.100 |
None |
0.756 |
123 |
|
2009 |
2020 |
Mammary Neoplasms
|
group |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
2780
|
385
|
0.400 |
None |
0.981 |
107 |
|
1991 |
2020 |
Secondary malignant neoplasm of lymph node
|
disease |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
2825
|
188
|
0.100 |
None |
0.907 |
54 |
|
1998 |
2019 |
Uterine Fibroids
|
group |
Neoplasms
|
Neoplastic Process
|
569
|
154
|
0.100 |
None |
0.950 |
40 |
|
1993 |
2019 |
Carcinoma
|
group |
Neoplasms
|
Neoplastic Process
|
2462
|
103
|
0.400 |
None |
0.970 |
33 |
|
1989 |
2018 |
Fibroid Tumor
|
disease |
Neoplasms
|
Neoplastic Process
|
413
|
14
|
0.100 |
None |
0.931 |
29 |
|
1993 |
2019 |
HER2 gene amplification
|
disease |
|
Disease or Syndrome
|
170
|
14
|
0.100 |
None |
0.778 |
27 |
|
1990 |
2019 |
Meningioma
|
disease |
Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
634
|
43
|
0.400 |
None |
0.963 |
27 |
|
1990 |
2020 |
Invasive carcinoma of breast
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
473
|
21
|
0.100 |
None |
0.913 |
23 |
|
1999 |
2019 |
Oestrogen receptor positive breast cancer
|
disease |
|
Neoplastic Process
|
510
|
58
|
0.100 |
None |
0.900 |
20 |
|
2005 |
2020 |
Progesterone Resistance
|
disease |
Female Urogenital Diseases and Pregnancy Complications
|
Disease or Syndrome
|
29
|
|
0.400 |
None |
1.000 |
19 |
|
2000 |
2019 |
Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6243
|
355
|
0.100 |
None |
0.944 |
18 |
|
1996 |
2019 |
Luminal A Breast Carcinoma
|
disease |
|
Neoplastic Process
|
153
|
11
|
0.100 |
None |
0.941 |
17 |
|
2010 |
2019 |
HER2-negative breast cancer
|
disease |
|
Neoplastic Process
|
160
|
18
|
0.100 |
None |
0.938 |
16 |
|
2011 |
2019 |
Noninfiltrating Intraductal Carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
486
|
13
|
0.100 |
None |
1.000 |
16 |
|
1998 |
2019 |
Meningioma, benign, no ICD-O subtype
|
disease |
Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
404
|
30
|
0.100 |
None |
0.933 |
15 |
|
1990 |
2019 |
Adult Meningioma
|
disease |
Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
405
|
30
|
0.100 |
None |
0.933 |
15 |
|
1990 |
2019 |